Complete remission of ALK-negative plasma cell granuloma (inflammatory myofibroblastic tumor) of the lung induced by celecoxib: A case report and review of the literature

Oncology Letters

Volumn 5, Issue 5, 2013, Pages 1672-1676

  Chavez, Cinderella ^a   Hoffman, Mark A ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

Cyclooxygenase 2 inhibitors; Inflammatory myofibroblastic tumor; Non steroidal anti inflammatory agents

Indexed keywords

CELECOXIB; IBUPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; ROFECOXIB; STEROID;

ABDOMINAL PAIN; ADULT; BODY TEMPERATURE DISORDER; CANCER REGRESSION; CASE REPORT; CELL INFILTRATION; COMPUTER ASSISTED TOMOGRAPHY; CURETTAGE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NODULE; LUNG PSEUDOTUMOR; LUNG TUMOR; MULTIPLE PULMONARY NODULES; PLASMA CELL GRANULOMA; REVIEW; THORAX RADIOGRAPHY;

EID: 84875709299     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1260     Document Type: Review

References (21)

1. Gleason BC and Hornick JL: Inflammatory myofibroblastic tumours: where are we now? J Clin Pathol 61: 428-437, 2008.
2. Coffin CM and Fletcher JA: Inflammatory myofibroblastic tumor. In: Fletcher CD, Unni KK and Mertens F (eds): World Health Organization Classification of Tumors: Pathology and Genetics of Soft Tissue and Bone. IARC Press, Lyon, pp91-93, 2002.
3. Coffin CM, Hornick JL and Fletcher CD: Inflammatory myoblastic tumor. Comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol 31: 509-520, 2007.
4. Kovach SJ, Fischer AC, Katzman PJ, Salloum RM, EttinghausenSE, Madeb R and Koniaris LG: Inflammatory myofibroblastic tumors. J Surg Oncol 94: 385-391, 2006.
5. Coffin CM, Watterson J, Priest JR and Dehner LP: Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol 19: 859-872, 1995.
6. Lee MH, Lee HB, Lee YC, Rhee YK, Lee EJ, Chung MJ, JinGY, Kweon EY and Park SJ: Bilateral multiple inflammatory myofibroblastic tumors of the lung successfully treated with corticosteroids. Lung 189: 433-435, 2011.
7. Carswell C and Chataway J: The successful long-term management of an intracranial inflammatory myoblastic tumor with corticosteroids. Clin Neurol Neurosurg 114: 77-79, 2012.
8. Hakozaki Y, Katou M, Nakagawa K, Shirahama T and MatsumotoT: Improvement of inflammatory pseudotumor of the liver after nonsteroidal anti-inflammatory agent therapy. Am J Gastroenterol 88: 1121-1122, 1993.
9. Imperato JP, Folkman J, Sagerman RH and Cassady JR: Treatment of plasma cell granuloma of the lung with radiation therapy. A report of two cases and review of the literature. Cancer 57: 2127-2129, 1986.
10. Bertocchini A, Lo Zupone C, Callea F, Gennari F, Serra A, MontiL and de Ville de Goyet J: Unresectable multifocal omental and peritoneal inflammatory myofibroblastic tumor in a child: revisiting the role of adjuvant therapy. J Pediatr Surg 46: e17-e21, 2011.
11. Butrynski JE, D'Adamo DR, Hornick JL, Dal Cin P, AntonescuCR, Jhanwar SC, Ladanyi M, Capelletti M, RodigSJ, RamaiyaN, KwakEL, Clark JW, Wilner KD, Christensen JG, Jänne PA, Maki RG, Demetri GD and Shapiro GI: Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. New Engl J Med 363: 1727-1733, 2010.
12. Su W, Ko A, O'Connell TX and Applebaum H: J Pediatr Surg 35: 1635-1637, 2000.
13. Chan PW, Omar KZ and Ramanujam TM: Successful treatment of unresectable inflammatory pseudotumor of the lung with COX-2 inhibitor. Pediatr Pulmonol 36: 167-169, 2003.
14. Przkora R, Bolder U, Schwartz S, Jauch KW, Spes J, AndreesonR and Mackensen A: Regression of nonresectable inflammatory myofibroblastic tumours after treatment with nonsteroidal anti-inflammatory drugs. Eur J Clin Invest 34: 320-321, 2004.
15. Colakoglu O, Unsal B, Haciyanli M, Tunakan M, Buyrac Z, Yorukoglu G, Yazicioglu N and Genc H: A successfully managed inflammatory pseudotumor of liver without surgery: report of a case. Acta Gastroenterol Belg 68: 382-384, 2005.
16. Vassiliadis T, Vougiouklis N, Patsiaoura K, MpoumponarisA, Nikolaidis N, Giouleme O and Evgenidis N: Inflammatory pseudotumor of the liver successfully treated with nonsteroidal anti-inflammatory drugs: a challenge diagnosis for one not so rare entity. Eur J Gastroenterol Hepatol 19: 1016-1020, 2007.
17. Mattei P and Barnaby K: Rapid regression of duodenal inflammatory myofibroblastic tumor after intravenous ketorolac: case report and review of the literature. J Pediatr Surg 43: 1196-1199, 2008.
18. Colangelo M, Lisi G and Chiesa PL: Pancreatic inflammatory myofibroblastic tumor (IMT). J Pediatr Surg 45: 1074-1075, 2009.
19. Liao Z, Mason K and Milas L: Cyclo-oxygenase-2 and its inhibition in cancer. Drugs 67: 821-846, 2007.
20. Masferrer JL, Leahy KM, Koki AT, Zweifel BS, Settle SL, Woerner BM, Edwards DA, Flickinger AG, Moore RJ and SeibertK: Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 60: 1306-1311, 2000.
21. Applebaum H, Kieran MW, Cripe TP, Coffin C, Collins MH, Kaipainen A, Laforme A and Shamberger RC: The rationale for nonsteroidal anti-inflammatory drug therapy for inflammatory myofibroblastic tumors: a Children's Oncology Group Study. J Pediatr Surg 40: 999-1003, 2005.